APM
TRIL

Avidity Partners Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Avidity Partners Management’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,105,000
Closed -$39.8M – 131
2021
Q2 		$39.8M Buy
4,105,000
+90,000
+2% +$873K 1.08% 35
2021
Q1 		$43.1M Buy
4,015,000
+829,800
+26% +$8.91M 1.19% 30
2020
Q4 		$46.9M Buy
3,185,200
+1,439,200
+82% +$21.2M 1.52% 19
2020
Q3 		$24.8M Buy
+1,746,000
New +$24.8M 1.15% 26